Item 2.01 Completion of Acquisition or Disposition of Assets
On June 8, 2022, Oracle Corporation, a Delaware corporation ("Oracle"),
completed its acquisition of Cerner Corporation, a Delaware corporation
("Cerner"), pursuant to the Agreement and Plan of Merger (the "Merger
Agreement"), dated December 20, 2021, among Oracle, Cerner, OC Acquisition LLC,
a Delaware limited liability company and wholly owned subsidiary of Oracle
("Parent"), and Cedar Acquisition Corporation, a Delaware corporation and wholly
owned subsidiary of Parent ("Purchaser").
Pursuant to the Merger Agreement and upon the terms and subject to the
conditions thereof, on January 19, 2022, Purchaser commenced a tender offer (the
"Offer") to purchase all of the issued and outstanding shares of common stock,
par value $0.01 per share (the "Shares"), of Cerner at a price of $95.00 per
Share (the "Offer Price"), net to the holders thereof, in cash, without interest
and subject to any required tax withholding.
The Offer expired at 12:00 midnight, Eastern Time, at the end of the day on
June 6, 2022 (the "Expiration Time"). According to American Stock Transfer &
Trust Company, LLC, the depositary for the Offer, as of the Expiration Time,
194,816,290 Shares had been validly tendered into and not validly withdrawn from
the Offer, representing approximately 66.0% of the outstanding Shares (not
including 9,464,299 Shares delivered through Notices of Guaranteed Delivery,
representing approximately 3.2% of the outstanding Shares). The number of Shares
validly tendered (and not validly withdrawn) pursuant to the Offer satisfied the
condition to the Offer that there be validly tendered (and not validly
withdrawn) prior to the Expiration Time a number of Shares (excluding Shares
tendered pursuant to guaranteed delivery procedures that have not yet been
delivered in settlement or satisfaction of such guaranteed delivery procedures)
that, together with any Shares owned by Oracle, Parent or Purchaser, represents
a majority of the aggregate number of Shares issued and outstanding immediately
prior to the first time Purchaser accepts any Shares for payment pursuant to the
Offer. All conditions to the Offer having been satisfied or waived, Purchaser
accepted for payment all Shares validly tendered and not validly withdrawn
pursuant to the Offer.
Following the consummation of the Offer, on June 8, 2022, Purchaser merged with
and into Cerner (the "Merger") upon the terms and subject to the conditions set
forth in the Merger Agreement and pursuant to Section 251(h) of the General
Corporation Law of the State of Delaware (the "DGCL"), with Cerner continuing as
the surviving corporation and becoming an indirect, wholly owned subsidiary of
Oracle. At the effective time of the Merger, each Share issued and outstanding
immediately prior to the effective time of the Merger (other than (i) Shares
held by Cerner as treasury stock or owned by Oracle, Parent, Purchaser or any
subsidiary of Cerner, or (ii) Shares held by stockholders who properly exercised
appraisal rights in accordance with Section 262 of the DGCL) was converted into
the right to receive the Offer Price, net to the holder in cash, without
interest thereon and subject to any required tax withholding.
Pursuant to the terms of the Merger Agreement, at the effective time of the
Merger, the unvested portion of each Cerner stock option, each Cerner restricted
stock award, each Cerner time-based restricted stock unit award, and each Cerner
performance-based restricted stock unit award (each, a "Cerner Compensatory
Award") that was outstanding immediately prior to the effective time of the
Merger and held by an employee of Cerner or any of its subsidiaries was assumed
by Oracle and converted automatically into a corresponding option, share of
restricted stock, restricted stock unit award or performance share unit award,
denominated in shares of Oracle common stock (with performance share unit awards
converted to time-vested awards based on the greater of target or actual
achievement of pro-rated performance goals through the effective time). The
vested portion of each Cerner Compensatory Award (including any portion that
pursuant to its terms became vested solely as a result of the transactions
contemplated by the Merger Agreement) that was outstanding immediately prior to
the effective time of the Merger was cancelled and extinguished and, in exchange
therefor,
--------------------------------------------------------------------------------
each former holder of any such vested portion of a Cerner Compensatory Award has
the right to receive (i) an amount in cash equal to the product of (x) the
aggregate number of shares of Cerner common stock subject to such vested portion
of the Cerner Compensatory Award immediately prior to the effective time of the
Merger and (y) the Offer Price less any per share exercise or purchase price of
such vested portion of the Cerner Compensatory Award immediately prior to such
cancellation and (ii) an amount equal to any dividend equivalent rights payable
with respect to such vested portion of the Cerner Compensatory Award. The
unvested portion of each Cerner Compensatory Award that was outstanding
immediately prior to the effective time of the Merger and held by a person who
was not an employee of Cerner or any of its subsidiaries was cancelled for no
consideration.
Oracle, Cerner, Parent and Purchaser intend to cause the delisting of the Shares
from the Nasdaq Global Select Market and the termination of the registration of
the Shares under the Securities Exchange Act of 1934, as amended, as soon after
completion of the Merger as the requirements for such delisting and termination
of registration are satisfied.
The foregoing description of the Merger Agreement and the transactions
contemplated thereby does not purport to be complete, and is qualified in its
entirety by reference to the full text of the Merger Agreement, which is
incorporated by reference herein from Exhibit 2.1 to the Current Report on
Form 8-K filed by Oracle with the Securities and Exchange Commission on
December 21, 2021.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant
As previously disclosed, on March 8, 2022, Oracle entered into a $15.7 billion
delayed draw term loan credit agreement (the "Bridge Credit Agreement"), which
provides for an unsecured $15.7 billion, 364-day term loan commitment (the
"Bridge Facility") to Oracle, subject to the satisfaction of certain customary
conditions.
On June 8, 2022, Oracle borrowed $15,700,000,000 under the Bridge Facility to
finance the acquisition of Cerner, repay certain indebtedness of Cerner or its
subsidiaries in connection with such acquisition, and to pay related fees and
expenses. All amounts borrowed under the Bridge Credit Agreement will become due
on March 7, 2023, unless the commitments and outstanding loans are terminated or
prepaid (as applicable) earlier (i) either at the request of Oracle, (ii) by the
lenders if an event of default occurs, or (iii) if a mandatory prepayment event
occurs. Interest is based on either (i) a Term SOFR-based formula plus a margin
of 100.0 basis points to 137.5 basis points, depending on the credit rating
assigned to Oracle's long-term senior unsecured debt, or (ii) a Base Rate
formula plus a margin of 0.0 basis points to 37.5 basis points, depending on the
same such credit rating, each as set forth in the Bridge Credit Agreement.
The foregoing description of the Bridge Credit Agreement does not purport to be
complete, and is qualified in its entirety by reference to the full text of the
Bridge Credit Agreement, which is incorporated by reference herein from
Exhibit 10.17 to the Quarterly Report on Form 10-Q filed by Oracle with
the Securities and Exchange Commission on March 11, 2022.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses